16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
Catastrophically injured car crash victims are concerned about how the new, rushed, and poorly draft...
Read More >
After quarter-on-quarter gains in Q1 and Q2 this year, global M&A value took a tumble in Q3, registe...
Read More >
Under North Carolina statute, employees who leave work for a reason other than good cause attributab...
Read More >
The Small Business Administration (SBA) recently issued a Procedural Notice (the Notice) containing ...
Read More >
(Still 100 percent guaranteed non-partisan.) The Democrats' debate this week in Charleston, South C...
Read More >
In yet another development in the closely watched case of Rizo v. Yovino, the en banc Ninth Circuit ...
Read More >